Literature DB >> 17265116

Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance.

Jason S Gold, Ronald P Dematteo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17265116     DOI： 10.1245/s10434-006-9291-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  10 in total

1.  Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors.

Authors:  Lin Xia; Ming-Ming Zhang; Lin Ji; Xin Li; Xiao-Ting Wu
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

2.  Effective Downsizing of a Gastroesophageal GIST Using Neoadjuvant Imatinib Mesylate: a Case Report.

Authors:  Syed Asif; Nikhil Gupta; Gurudutt Gupta; Anurag Mehta; Shivendra Singh
Journal:  J Gastrointest Cancer       Date:  2017-06

3.  Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: report of a case.

Authors:  Takashi Akiyoshi; Masatoshi Oya; Yoshiya Fujimoto; Hiroya Kuroyanagi; Masashi Ueno; Toshiharu Yamaguchi; Shunji Takahashi; Kiyohiko Hatake; Masamichi Katori; Noriko Yamamoto; Tetsuichiro Muto
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

4.  Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.

Authors:  Ryan S Turley; Peter D Peng; Srinevas K Reddy; Andrew S Barbas; David A Geller; J Wallis Marsh; Allan Tsung; Timothy M Pawlik; Bryan M Clary
Journal:  Cancer       Date:  2011-11-15       Impact factor: 6.860

5.  Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.

Authors:  Katarina Sjölund; Anna Andersson; Erik Nilsson; Ola Nilsson; Håkan Ahlman; Bengt Nilsson
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

6.  Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).

Authors:  Sumin Tang; Yuan Yin; Chaoyong Shen; Jiaju Chen; Xiaonan Yin; Bo Zhang; Yuqin Yao; Jinliang Yang; Zhixin Chen
Journal:  World J Surg Oncol       Date:  2017-04-11       Impact factor: 2.754

7.  Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach.

Authors:  Gustavo dos Santos Fernandes; Guilherme Cutait de Castro Cotti; Daniela Freitas; Raul Cutait; Paulo M Hoff
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

8.  Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II Trial.

Authors:  C Doyon; L Sidéris; G Leblanc; Y E Leclerc; D Boudreau; P Dubé
Journal:  Int J Surg Oncol       Date:  2012-12-17

9.  A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report.

Authors:  Senichiro Yanagawa; Kazuaki Tanabe; Takahisa Suzuki; Noriaki Tokumoto; Koji Arihiro; Hideki Ohdan
Journal:  World J Surg Oncol       Date:  2014-02-27       Impact factor: 2.754

10.  The 100 Most Influential Papers and Recent Trends in the Field of Gastrointestinal Stromal Tumours: A Bibliometric Analysis.

Authors:  Khadijah Siddiq; Hira F Akbar; Meeshal Khan; Amna A Siddiqui; Salman Nusrat; Jean Y Blay
Journal:  Cureus       Date:  2018-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.